» Articles » PMID: 35339759

MicroRNA-181a-5p Impedes the Proliferation, Migration, and Invasion of Retinoblastoma Cells by Targeting the NRAS Proto-oncogene

Overview
Publisher Elsevier
Specialty General Medicine
Date 2022 Mar 27
PMID 35339759
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: Accumulating research have reported that microRNAs (miRNAs) play important roles in Retinoblastoma (RB). Nonetheless, the function and underlying mechanism of miR-181a-5p in RB remain ambiguous.

Methods: The relative expression levels of miR-181a-5p and NRAS mRNA were detected by quantitative Reverse Transcription-Polymerase Chain Reaction (qRT-PCR). RB cell proliferation was measured using the Cell Counting Kit-8 (CCK-8) and 5'-Bromo-2'-deoxyuridine (BrdU) assays. Transwell assays and flow cytometry were performed to detect the migration, invasion, and apoptosis of RB cells. The interaction between miR-181a-5p and NRAS was explored using luciferase experiments, western blotting, and qRT-PCR.

Results: miR-181a-5p expression was found to be decreased in RB tissues and cell lines, and its expression was correlated with unfavorable pathological features of the patients. In vitro experiments revealed that miR-181a-5p reduced RB cell proliferation, migration, and invasion while enhancing apoptosis. Further research confirmed that NRAS is a direct target of miR-181a-5p. miR-181a-5p inhibited NRAS expression at both the mRNA and protein levels. Co-transfection of pcDNA-NRAS or NRAS small interfering RNA (siRNA) reversed the effects of miR-181a-5p mimics or miR-181a-5p inhibitors on RB cells.

Conclusion: miR-181a-5p was significantly downregulated during the development of RB, and it suppressed the malignant behaviors of RB cells by targeting NRAS.

Citing Articles

hsa-miR-181a-5p inhibits glioblastoma development via the MAPK pathway: and study.

Shadbad M, Baradaran B Oncol Res. 2024; 32(12):1949-1958.

PMID: 39574474 PMC: 11576920. DOI: 10.32604/or.2024.051569.


Molecular Biological Research on the Pathogenic Mechanism of Retinoblastoma.

Ma X, Li X, Sun Q, Luan F, Feng J Curr Issues Mol Biol. 2024; 46(6):5307-5321.

PMID: 38920989 PMC: 11202574. DOI: 10.3390/cimb46060317.


An integrated analysis of dysregulated SCD1 in human cancers and functional verification of miR-181a-5p/SCD1 axis in esophageal squamous cell carcinoma.

Wang B, Chang Y, Shiu L, Lee Y, Lin Y, Hsu Y Comput Struct Biotechnol J. 2023; 21:4030-4043.

PMID: 37664175 PMC: 10468324. DOI: 10.1016/j.csbj.2023.08.009.


Recent Advances in Extracellular Vesicles in Amyotrophic Lateral Sclerosis and Emergent Perspectives.

Afonso G, Cavaleiro C, Valero J, Mota S, Ferreiro E Cells. 2023; 12(13).

PMID: 37443797 PMC: 10340215. DOI: 10.3390/cells12131763.


MiR-181a-5p inhibits uveal melanoma development by targeting GNAQ and AKT3.

Wang R, Tahiri H, Yang C, Landreville S, Callejo S, Hardy P Am J Cancer Res. 2023; 13(1):293-306.

PMID: 36777504 PMC: 9906069.


References
1.
Mi Y, Zhang D, Jiang W, Weng J, Zhou C, Huang K . miR-181a-5p promotes the progression of gastric cancer via RASSF6-mediated MAPK signalling activation. Cancer Lett. 2017; 389:11-22. DOI: 10.1016/j.canlet.2016.12.033. View

2.
Fabian I, Onadim Z, Karaa E, Duncan C, Chowdhury T, Scheimberg I . The management of retinoblastoma. Oncogene. 2018; 37(12):1551-1560. DOI: 10.1038/s41388-017-0050-x. View

3.
Dietrich P, Gaza A, Wormser L, Fritz V, Hellerbrand C, Bosserhoff A . Neuroblastoma RAS Viral Oncogene Homolog (NRAS) Is a Novel Prognostic Marker and Contributes to Sorafenib Resistance in Hepatocellular Carcinoma. Neoplasia. 2019; 21(3):257-268. PMC: 6370713. DOI: 10.1016/j.neo.2018.11.011. View

4.
Yang M, Zhai X, Ge T, Yang C, Lou G . miR-181a-5p Promotes Proliferation and Invasion and Inhibits Apoptosis of Cervical Cancer Cells via Regulating Inositol Polyphosphate-5-Phosphatase A (INPP5A). Oncol Res. 2017; 26(5):703-712. PMC: 7844749. DOI: 10.3727/096504017X14982569377511. View

5.
Yang Y, Mei Q . miRNA signature identification of retinoblastoma and the correlations between differentially expressed miRNAs during retinoblastoma progression. Mol Vis. 2016; 21:1307-17. PMC: 4688417. View